Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus

European Journal of Endocrinology

Volumn 172, Issue 4, 2015, Pages R167-R177

  Allin, Kristine H ^a   Nielsen, Trine ^a   Pedersen, Oluf ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BILE ACID; GLUCOSE; INSULIN; LIPOPOLYSACCHARIDE; METFORMIN; RNA 16S; SHORT CHAIN FATTY ACID;

ANTIBIOTIC THERAPY; BACTERIUM IDENTIFICATION; BILE ACID METABOLISM; CARBOHYDRATE METABOLISM; CLOSTRIDIUM; EUBACTERIUM; FATTY ACID METABOLISM; GENE SEQUENCE; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIFESTYLE; METAGENOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PREVOTELLA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; ANIMAL; GASTROINTESTINAL TRACT; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIOLOGY; MICROFLORA; MOUSE; PHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICROBIOTA;

EID: 84927668122     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0874     Document Type: Review

References (72)

1. Grarup N, Sandholt CH, Hansen T & Pedersen O. Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond. Diabetologia 2014 57 1528-1541. (doi:10.1007/s00125-014-3270-4)
2. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010 464 59-65. (doi:10.1038/nature08821)
3. Tremaroli V & Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012 489 242-249. (doi:10.1038/nature11552)
4. Kuczynski J, Lauber CL, Walters WA, Parfrey LW, Clemente JC, Gevers D & Knight R. Experimental and analytical tools for studying the human microbiome. Nature Reviews. Genetics 2012 13 47-58. (doi:10.1038/nrg3129)
5. Weinstock GM. Genomic approaches to studying the human microbiota. Nature 2012 489 250-256. (doi:10.1038/nature11553)
6. Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, Arumugam M, Kultima JR, Prifti E, Nielsen T et al. An integrated catalog of reference genes in the human gut microbiome. Nature Biotechnology 2014 32 834-841. (doi:10.1038/nbt.2942)
7. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF & Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. PNAS 2004 101 15718-15723. (doi:10.1073/pnas.0407076101)
8. Backhed F, Manchester JK, Semenkovich CF & Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. PNAS 2007 104 979-984. (doi:10.1073/pnas.0605374104)
9. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012 490 55-60. (doi:10.1038/nature11450)
10. Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B, Nielsen J & Backhed F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013 498 99-103. (doi:10.1038/nature12198)
11. Ley RE, Turnbaugh PJ, Klein S & Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006 444 1022-1023. (doi:10.1038/4441022a)
12. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER & Gordon JI. An obesity-associated gutmicrobiome with increased capacity for energy harvest. Nature 2006 444 1027-1031. (doi:10.1038/nature05414)
13. Le CE, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013 500 541-546. (doi:10.1038/nature12506)
14. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sorensen SJ, Hansen LH & Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010 5 e9085. (doi:10.1371/journal.pone.0009085)
15. Shin NR, Lee JC, Lee HY, Kim MS, Whon TW, Lee MS & Bae JW. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014 63 727-735. (doi:10.1136/gutjnl-2012-303839)
16. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. PNAS 2013 110 9066-9071. (doi:10.1073/pnas.1219451110)
17. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007 56 1761-1772. (doi:10.2337/db06-1491)
18. Erridge C, Attina T, Spickett CM & Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. American Journal of Clinical Nutrition 2007 86 1286-1292.
19. Harte AL, Varma MC, Tripathi G, McGee KC, Al-Daghri NM, Al-Attas OS, Sabico S, O'Hare JP, Ceriello A, Saravanan P et al. High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care 2012 35 375-382. (doi:10.2337/dc11-1593)
20. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F & Wu GD. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009 137 1716-1724. (doi:10.1053/j.gastro.2009.08.042)
21. Rabot S, Membrez M, Bruneau A, Gerard P, Harach T, Moser M, Raymond F, Mansourian R & Chou CJ. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB Journal 2010 24 4948-4959. (doi:10.1096/fj.10-164921)
22. Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, Corthesy I, Mace K & Chou CJ. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB Journal 2008 22 2416-2426. (doi:10.1096/fj.07-102723)
23. Caricilli AM, Picardi PK, de Abreu LL, Ueno M, Prada PO, Ropelle ER, Hirabara SM, Castoldi A, Vieira P, Camara NO et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biology 2011 9 e1001212. (doi:10.1371/journal.pbio.1001212)
24. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE & Gewirtz AT. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010 328 228-231. (doi:10.1126/science.1179721)
25. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012 482 179-185. (doi:10.1038/nature10809)
26. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT & Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009 58 1509-1517. (doi:10.2337/db08-1637)
27. Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 2012 7 e35240. (doi:10.1371/journal.pone.0035240)
28. Wichmann A, Allahyar A, Greiner TU, Plovier H, Lunden GO, Larsson T, Drucker DJ, Delzenne NM, Cani PD & Backhed F. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host & Microbe 2013 14 582-590. (doi:10.1016/j.chom.2013.09.012)
29. Brahe LK, Astrup A & Larsen LH. Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? Obesity Reviews 2013 14 950-959. (doi:10.1111/obr.12068)
30. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F & Gribble FM. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012 61 364-371. (doi:10.2337/db11-1019)
31. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009 461 1282-1286. (doi:10.1038/nature08530)
32. De VF, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Backhed F & Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014 156 84-96. (doi:10.1016/j.cell.2013.12.016)
33. Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, Pruzanski M et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metabolism 2009 10 167-177. (doi:10.1016/j.cmet.2009.08.001)
34. Vrieze A, Out C, Fuentes S, Jonker L, Reuling I, Kootte RS, van NE, Holleman F, Knaapen M, Romijn JA et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. Journal of Hepatology 2014 60 824-831. (doi:10.1016/j.jhep.2013.11.034)
35. Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, Wilson-Perez HE, Sandoval DA, Kohli R, Backhed F et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014 509 183-188. (doi:10.1038/nature13135)
36. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009 58 1091-1103. (doi:10.1136/gut.2008.165886)
37. Tims S, Derom C, Jonkers DM, Vlietinck R, Saris WH, Kleerebezem M, de Vos WM & Zoetendal EG. Microbiota conservation and BMI signatures in adult monozygotic twins. ISME Journal 2013 7 707-717. (doi:10.1038/ismej.2012.146)
38. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP et al. A core gut microbiome in obese and lean twins. Nature 2009 457 480-484. (doi:10.1038/nature07540)
39. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT et al. Human genetics shape the gut microbiome. Cell 2014 159 789-799. (doi:10.1016/j.cell.2014.09.053)
40. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R & Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Science Translational Medicine 2009 1 6ra14. (doi:10.1126/scitranslmed.3000322)
41. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O'Sullivan O et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012 488 178-184. (doi:10.1038/nature11319)
42. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014 505 559-563. (doi:10.1038/nature12820)
43. De FC, Cavalieri D, Di PM, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G & Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. PNAS 2010 107 14691-14696. (doi:10.1073/pnas.0914454107)
44. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011 334 105-108. (doi:10.1126/science.1208344)
45. Knights D, Ward TL, McKinlay CE, Miller H, Gonzalez A, McDonald D & Knight R. Rethinking "enterotypes". Cell Host & Microbe 2014 16 433-437. (doi:10.1016/j.chom.2014.09.013)
46. Arumugam M, Raes J, Pelletier E, Le PD, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM et al. Enterotypes of the human gut microbiome. Nature 2011 473 174-180. (doi:10.1038/nature09944)
47. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013 341 1241214. (doi:10.1126/science.1241214)
48. Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014 514 181-186. (doi:10.1038/nature13793)
49. Clarke SF, Murphy EF, O'Sullivan O, Lucey AJ, Humphreys M, Hogan A, Hayes P, O'Reilly M, Jeffery IB, Wood-Martin R et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut 2014 63 1913-1920. (doi:10.1136/gutjnl-2013-306541)
50. Biedermann L, Brulisauer K, Zeitz J, Frei P, Scharl M, Vavricka SR, Fried M, Loessner MJ, Rogler G & Schuppler M. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflammatory Bowel Diseases 2014 20 1496-1501. (doi:10.1097/MIB.0000000000000129)
51. Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Starkel P, Windey K, Tremaroli V, Backhed F, Verbeke K et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. PNAS 2014 111 E4485-E4493. (doi:10.1073/pnas.1415174111)
52. Ajslev TA, Andersen CS, Gamborg M, Sorensen TI & Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. International Journal of Obesity 2011 35 522-529. (doi:10.1038/ijo.2011.27)
53. Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A & DeRusso PA. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatrics 2014 168 1063-1069. (doi:10.1001/jamapediatrics.2014.1539)
54. Murphy R, Stewart AW, Braithwaite I, Beasley R, Hancox RJ & Mitchell EA. Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study. International Journal of Obesity 2014 38 1115-1119. (doi:10.1038/ijo.2013.218)
55. Trasande L, Blustein J, Liu M, Corwin E, Cox LM & Blaser MJ. Infant antibiotic exposures and early-life body mass. International Journal of Obesity 2013 37 16-23. (doi:10.1038/ijo.2012.132)
56. Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012 488 621-626. (doi:10.1038/nature11400)
57. Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, Kim SG, Li H, Gao Z, Mahana D et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014 158 705-721. (doi:10.1016/j.cell.2014.05.052)
58. Thuny F, Richet H, Casalta JP, Angelakis E, Habib G & Raoult D. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS ONE 2010 5 e9074. (doi:10.1371/journal.pone.0009074)
59. Carvalho BM, Guadagnini D, Tsukumo DM, Schenka AA, Latuf-Filho P, Vassallo J, Dias JC, Kubota LT, Carvalheira JB & Saad MJ. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 2012 55 2823-2834. (doi:10.1007/s00125-012-2648-4)
60. Ley RE, Peterson DA & Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006 124 837-848. (doi:10.1016/j.cell.2006.02.017)
61. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N & Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. PNAS 2010 107 11971-11975. (doi:10.1073/pnas.1002601107)
62. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, Angenent LT & Ley RE. Succession of microbial consortia in the developing infant gut microbiome. PNAS 2011 108 (Suppl 1) 4578-4585. (doi:10.1073/pnas.1000081107)
63. Palmer C, Bik EM, DiGiulio DB, Relman DA & Brown PO. Development of the human infant intestinal microbiota. PLoS Biology 2007 5 e177. (doi:10.1371/journal.pbio.0050177)
64. Spor A, Koren O & Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nature Reviews. Microbiology 2011 9 279-290. (doi:10.1038/nrmicro2540)
65. Yuan S, Cohen DB, Ravel J, Abdo Z & Forney LJ. Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS ONE 2012 7 e33865. (doi:10.1371/journal.pone.0033865)
66. Goodrich JK, Di Rienzi SC, Poole AC, Koren O, Walters WA, Caporaso JG, Knight R & Ley RE. Conducting a microbiome study. Cell 2014 158 250-262. (doi:10.1016/j.cell.2014.06.037)
67. Donia MS, Cimermancic P, Schulze CJ, Wieland Brown LC, Martin J, Mitreva M, Clardy J, Linington RG & Fischbach MA. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 2014 158 1402-1414. (doi:10.1016/j.cell.2014.08.032)
68. Vrieze A, van NE, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012 143 913-916. (doi:10.1053/j.gastro.2012.06.031)
69. Shanahan F. The gut microbiota-a clinical perspective on lessons learned. Nature Reviews. Gastroenterology & Hepatology 2012 9 609-614. (doi:10.1038/nrgastro.2012.145)
70. Graessler J, Qin Y, Zhong H, Zhang J, Licinio J, Wong ML, Xu A, Chavakis T, Bornstein AB, Ehrhart-Bornstein M et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics Journal 2013 13 514-522. (doi:10.1038/tpj.2012.43)
71. Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y & Ji L. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE 2013 8 e71108. (doi:10.1371/journal.pone.0071108)
72. Napolitano A, Miller S, Nicholls AW, Baker D, Van HS, Thomas E, Rajpal D, Spivak A, Brown JR & Nunez DJ. Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS ONE 2014 9 e100778. (doi:10.1371/journal.pone.0100778)